Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

Praxis: Moving To Strong Buy Based On Ulixacaltamide Success In Treating ET

Praxis Precision Medicines, Inc. is upgraded to Strong Buy, driven by pipeline progress and positive Phase 3 data for ...

Queen Square launches podcast to support Parkinson's and Essential Tremor patients

Queen Square Imaging Centre – the world-leading centre treating patients with Essential Tremor and Parkinson's - has launched ...
Frontiers

Redefining Tremor Syndromes: Precision Medicine through Phenotyping and Biomarkers

The field of movement disorders, particularly tremor syndromes, is undergoing a transformative shift driven by advancements in precision medicine. Tremor, a ...